Therefore, the faint inflammatory reaction observed in AD-CL3 cluster could explain the slower disease progression that characterizes this group and leaves the door open to possible interventions aimed at mitigating the severity of the disease. The gene discussed is ADGRL3; the disease is Alzheimer disease.